BLESS MICHAEL A
BLESS MICHAEL A's purchase track record
BLESS MICHAEL A has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/10/2022 | CNA | $110K | -7.2% | -2.9% | -4.3% |
| 5/10/2022 | ACT | $110K | +17.2% | +17.1% | -4.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
CNA Financial Faces Insurance Pricing Pressure Amid Sector Review. Recent reports question whether CNA Financial can maintain growth as insurance pricing softens, a key challenge for the carrier. While higher interest rates are supporting other US insurance stocks, CNA is currently trading at a discount to its industry peers. The stock is also sitting near a significant support level, reflecting cautious sentiment among investors.
Transaction History
| ACT | ▲ Buy | Open Market | 5,000 | $110K | 5/10/2022 | View on chart |
| CNA | ▲ Buy | Open Market | 2,500 | $110K | 5/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Enact Holdings Reports Q2 Earnings and Reinsurance Deal
Enact Holdings released its Q2 2026 earnings results and announced a new forward quota share reinsurance transaction to diversify credit risk. The company also received affirmed credit ratings from AM Best. These developments provide context for the stock's current valuation, which sits below the average analyst target price.
Enact Holdings Reports Q2 Earnings and Reinsurance Deal. Enact Holdings released its Q2 2026 earnings results and announced a new forward quota share reinsurance transaction to diversify credit risk. The company also received affirmed credit ratings from AM Best. These developments provide context for the stock's current valuation, which sits below the average analyst target price.